Breakthrough Gene Therapy Trial Aims to Cure Deafness

The world's first clinical trial for a gene therapy to cure a form of deafness has begun. The trial aims to restore hearing in patients with a specific genetic mutation that causes profound deafness. The therapy involves injecting a harmless virus carrying a corrected version of the faulty gene into the inner ear. If successful, this groundbreaking treatment could offer hope to millions of people worldwide suffering from genetic hearing loss.